Lucinactant - CISMeF

Preferred Label : Lucinactant;

NCIt synonyms : KL4-surfactant;

NCIt definition : A synthetic pulmonary surfactant composed of sinapultide (KL4 peptide), phospholipids, including dipalmitoylphosphatidylcholine (DPPC) and palmitoyloleoyl phosphatidylglycerol (POPG), and palmitic acid, with surfactant activity. Upon administration, lucinactant mimics endogenous pulmonary surfactant and lines the alveoli and smallest bronchioles, thereby keeping alveoli open during expiration by lowering surface tension. This improves lung function, respiratory gas exchange and oxygenation.;

UNII : 5BSH2G9BH8;

CAS number : 825600-90-6; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 825600-90-6 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Surfaxin;

Molecule name : API 02; ATI 02;

NCI Metathesaurus CUI : CL1406698;

Details

Origin ID

C172611;

UMLS CUI

C1609686;

Automatic exact mappings (from CISMeF team)
- KL4 surfactant [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
- Lucinactant (substance) [SNOMED CT concept]
- lucinactant [MeSH Supplementary Concept]
- lucinactant [MeSH concept]
See also inter- (CISMeF)
- Product containing lucinactant (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Lucinactant (substance) [SNOMED CT concept]
- Product containing lucinactant (medicinal product) [SNOMED CT concept]
- lucinactant [MeSH Supplementary Concept]
- lucinactant [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients